Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice
Identifieur interne : 003581 ( Main/Merge ); précédent : 003580; suivant : 003582Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice
Auteurs : Anne-Sophie Villégier [France] ; Candice Drouin [France] ; Jean-Charles Bizot [France] ; Marc Marien [France] ; Jacques Glowinski [France] ; Francis Colpaërt [France] ; Jean-Pol Tassin [France]Source :
- Synapse [ 0887-4476 ] ; 2003-12-15.
English descriptors
- KwdEn :
Abstract
Recent experiments have shown that mice lacking the α1b‐adrenergic receptor (α1b‐AR KO) are less responsive to the locomotor hyperactivity induced by psychostimulants, such as D‐amphetamine or cocaine, than their wild‐type littermates (WT). These findings suggested that psychostimulants induce locomotor hyperactivity not only because they increase dopamine (DA) transmission, but also because they release norepinephrine (NE). To test whether NE release could increase DA‐mediated locomotor hyperactivity, rats were treated with GBR 12783 (10 mg/kg), a specific inhibitor of the DA transporter, and NE release was enhanced with dexefaroxan (0.63–10 mg/kg), a potent and specific antagonist at α2‐adrenergic receptors. Dexefaroxan increased the GBR 12783‐mediated locomotor response by almost 8‐fold. The role of α1b‐ARs in this effect was then verified in α1b‐AR KO mice: whereas dexefaroxan (1 mg/kg) doubled locomotor hyperactivity induced by GBR 12783 (14 mg/kg) in WT mice, it decreased it by 43% in α1b‐AR KO mice. Finally, to test whether this latter inhibition was related to the occupation of α2‐adrenergic autoreceptors or of α2‐ARs not located on noradrenergic neurons, effects of dexefaroxan on locomotor hyperactivity induced by D‐amphetamine (0.75 mg/kg) were monitored in rats depleted in ascending noradrenergic neurons. In these animals dexefaroxan inhibited by 25–70% D‐amphetamine‐induced locomotor hyperactivity. These data indicate not only that the stimulation of α1b‐ARs increases DA‐mediated locomotor response, but also suggest a significant implication of postsynaptic α2‐ARs. Involvement of these adrenergic receptor mechanisms may be exploited in the therapy of Parkinson's disease. Synapse 50:277–284, 2003. © 2003 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/syn.10267
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C26
- to stream Istex, to step Curation: 001C24
- to stream Istex, to step Checkpoint: 000C62
Links to Exploration step
ISTEX:2A2CFDAB5313C531CC3DD9B09F6F10205A1560F6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice</title>
<author><name sortKey="Villegier, Anne Ophie" sort="Villegier, Anne Ophie" uniqKey="Villegier A" first="Anne-Sophie" last="Villégier">Anne-Sophie Villégier</name>
</author>
<author><name sortKey="Drouin, Candice" sort="Drouin, Candice" uniqKey="Drouin C" first="Candice" last="Drouin">Candice Drouin</name>
</author>
<author><name sortKey="Bizot, Jean Harles" sort="Bizot, Jean Harles" uniqKey="Bizot J" first="Jean-Charles" last="Bizot">Jean-Charles Bizot</name>
</author>
<author><name sortKey="Marien, Marc" sort="Marien, Marc" uniqKey="Marien M" first="Marc" last="Marien">Marc Marien</name>
</author>
<author><name sortKey="Glowinski, Jacques" sort="Glowinski, Jacques" uniqKey="Glowinski J" first="Jacques" last="Glowinski">Jacques Glowinski</name>
</author>
<author><name sortKey="Colpaert, Francis" sort="Colpaert, Francis" uniqKey="Colpaert F" first="Francis" last="Colpaërt">Francis Colpaërt</name>
</author>
<author><name sortKey="Tassin, Jean Ol" sort="Tassin, Jean Ol" uniqKey="Tassin J" first="Jean-Pol" last="Tassin">Jean-Pol Tassin</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2A2CFDAB5313C531CC3DD9B09F6F10205A1560F6</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/syn.10267</idno>
<idno type="url">https://api.istex.fr/document/2A2CFDAB5313C531CC3DD9B09F6F10205A1560F6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C26</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C26</idno>
<idno type="wicri:Area/Istex/Curation">001C24</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C62</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C62</idno>
<idno type="wicri:doubleKey">0887-4476:2003:Villegier A:stimulation:of:postsynaptic</idno>
<idno type="wicri:Area/Main/Merge">003581</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice</title>
<author><name sortKey="Villegier, Anne Ophie" sort="Villegier, Anne Ophie" uniqKey="Villegier A" first="Anne-Sophie" last="Villégier">Anne-Sophie Villégier</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U. 114, Collège de France, 75231 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Drouin, Candice" sort="Drouin, Candice" uniqKey="Drouin C" first="Candice" last="Drouin">Candice Drouin</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U. 114, Collège de France, 75231 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bizot, Jean Harles" sort="Bizot, Jean Harles" uniqKey="Bizot J" first="Jean-Charles" last="Bizot">Jean-Charles Bizot</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Key‐Obs SA, Centre d'innovation, 45074 Orléans</wicri:regionArea>
<placeName><region type="region" nuts="2">Centre-Val de Loire</region>
<region type="old region" nuts="2">Région Centre</region>
<settlement type="city">Orléans</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marien, Marc" sort="Marien, Marc" uniqKey="Marien M" first="Marc" last="Marien">Marc Marien</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Recherche Pierre Fabre, 81100 Castres</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Castres</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Glowinski, Jacques" sort="Glowinski, Jacques" uniqKey="Glowinski J" first="Jacques" last="Glowinski">Jacques Glowinski</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U. 114, Collège de France, 75231 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Colpaert, Francis" sort="Colpaert, Francis" uniqKey="Colpaert F" first="Francis" last="Colpaërt">Francis Colpaërt</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Recherche Pierre Fabre, 81100 Castres</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Castres</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tassin, Jean Ol" sort="Tassin, Jean Ol" uniqKey="Tassin J" first="Jean-Pol" last="Tassin">Jean-Pol Tassin</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U. 114, Collège de France, 75231 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U. 114, Collège de France, 11, Place Marcelin Berthelot, 75231 Paris Cedex 05</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Synapse</title>
<title level="j" type="abbrev">Synapse</title>
<idno type="ISSN">0887-4476</idno>
<idno type="eISSN">1098-2396</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-12-15">2003-12-15</date>
<biblScope unit="volume">50</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="277">277</biblScope>
<biblScope unit="page" to="284">284</biblScope>
</imprint>
<idno type="ISSN">0887-4476</idno>
</series>
<idno type="istex">2A2CFDAB5313C531CC3DD9B09F6F10205A1560F6</idno>
<idno type="DOI">10.1002/syn.10267</idno>
<idno type="ArticleID">SYN10267</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0887-4476</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>6‐OHDA</term>
<term>D‐amphetamine</term>
<term>GBR 12783</term>
<term>NE‐depletion</term>
<term>dexefaroxan</term>
<term>α1b‐adrenergic receptor knockout mice</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recent experiments have shown that mice lacking the α1b‐adrenergic receptor (α1b‐AR KO) are less responsive to the locomotor hyperactivity induced by psychostimulants, such as D‐amphetamine or cocaine, than their wild‐type littermates (WT). These findings suggested that psychostimulants induce locomotor hyperactivity not only because they increase dopamine (DA) transmission, but also because they release norepinephrine (NE). To test whether NE release could increase DA‐mediated locomotor hyperactivity, rats were treated with GBR 12783 (10 mg/kg), a specific inhibitor of the DA transporter, and NE release was enhanced with dexefaroxan (0.63–10 mg/kg), a potent and specific antagonist at α2‐adrenergic receptors. Dexefaroxan increased the GBR 12783‐mediated locomotor response by almost 8‐fold. The role of α1b‐ARs in this effect was then verified in α1b‐AR KO mice: whereas dexefaroxan (1 mg/kg) doubled locomotor hyperactivity induced by GBR 12783 (14 mg/kg) in WT mice, it decreased it by 43% in α1b‐AR KO mice. Finally, to test whether this latter inhibition was related to the occupation of α2‐adrenergic autoreceptors or of α2‐ARs not located on noradrenergic neurons, effects of dexefaroxan on locomotor hyperactivity induced by D‐amphetamine (0.75 mg/kg) were monitored in rats depleted in ascending noradrenergic neurons. In these animals dexefaroxan inhibited by 25–70% D‐amphetamine‐induced locomotor hyperactivity. These data indicate not only that the stimulation of α1b‐ARs increases DA‐mediated locomotor response, but also suggest a significant implication of postsynaptic α2‐ARs. Involvement of these adrenergic receptor mechanisms may be exploited in the therapy of Parkinson's disease. Synapse 50:277–284, 2003. © 2003 Wiley‐Liss, Inc.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003581 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003581 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:2A2CFDAB5313C531CC3DD9B09F6F10205A1560F6 |texte= Stimulation of postsynaptic α1b‐ and α2‐adrenergic receptors amplifies dopamine‐mediated locomotor activity in both rats and mice }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |